Novartis Canada launches new head office in the Health Innovation District of Montréal, featuring a unique environment to inspire co-creation, partnerships and continued healthcare innovation
Novartis has a long-standing history in Canada, and is committed to delivering improved outcomes for millions of patients. In 2022, Novartis invested a total of $450 million in Canada.
The office has been optimized for hybrid working with state-of-the-art technology, a variety of working spaces and enhanced amenities to support our 650 associates located across Quebec.
Novartis Canada's tenancy at Place Gare Viger, in the historic district of Montréal, places the Company directly in the heart of a flourishing ecosystem of organizations dedicated to the creation and exchange of innovative ideas.
Novartis Pharmaceuticals Canada Inc. (Novartis) is pleased to announce the official opening of its new Montréal office in the heart of Old Montréal. Located in the iconic Place Gare Viger, the office has been designed to provide a modern workplace that meets the needs of Novartis' associates and facilitates closer collaboration with key stakeholders.
"We are thrilled to be part of this progressive and invigorating district of Montréal as we continue to reimagine medicine," said Andrea Marazzi, Country President, Novartis Pharmaceuticals Canada Inc. "Our new head office puts us closer to our stakeholders and has been developed to facilitate true collaboration and partnership. Our office will also feature a dedicated space for the BIOME by Novartis, the hub within Novartis to facilitate dynamic partnerships and collaboration focused on delivering impactful healthcare solutions for better patient outcomes. We are excited to welcome our stakeholders to our new Montréal home."